Article

CRISPR/Cas9 screenings unearth protein arginine methyltransferase 7 as a novel driver of metastasis in prostate cancer

2023-09-18

Abstract excerpt

<title>Abstract</title> <p>Owing to the inefficacy of available treatments, the survival rate of patients with metastatic prostate cancer (mPCa) is severely decreased. Therefore, it is crucial to identify new therapeutic targets to increase the survival of mPCa patients. This study aim was to identify the most relevant regulators of mPCa onset by performing two high-throughput CRISPR/Cas9 screenings. Furthermore,...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 87707132-6b45-5292-a252-f918aea5ecb3
DOI: 10.21203/rs.3.rs-3316991/v1

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

CRISPR/Cas9 screenings unearth protein arginine methyltransferase 7 as a novel driver of metastasis in prostate cancerDOI 10.21203/rs.3.rs-3316991/v1Read

CRISPR/Cas9 Technology Providing a Therapeutic Landscape of Metastatic Prostate CancerSemantic proximity Read

CRISPR screening reveals SYCP3 as a key driver of metastasis in prostate cancerSemantic proximity Read

A genome-scale CRISPR screen reveals PRMT1 as a critical regulator of androgen receptor signaling in prostate cancerSemantic proximity Read

Protein arginine methyltransferase 7 suppresses migration and invasion in prostate cancer cells in vitroSemantic proximity Read

CRISPR/Cas9 model of prostate cancer identifies Kmt2c deficiency as a metastatic driver by Odam/Cabs1 gene cluster expressionSemantic proximity Read

CRISPR Screen Contributes to Novel Target Discovery in Prostate CancerSemantic proximity Read

CRISPR/Cas9 model of prostate cancer identifies Kmt2c deficiency as a metastatic driver by Odam/Cabs1 gene cluster expressionSemantic proximity Read

PRMT5-exacerbating tumor stemness and immunosuppression confer a novel immunotherapeutic vulnerability in aggressive prostate cancerSemantic proximity Read

Targeting mRNA-coding genes in prostate cancer using CRISPR/Cas9 technology with a special focus on androgen receptor signalingSemantic proximity Read

Integrative CRISPR-Cas9 Screening Reveals Lethal Genes Driving Metastasis and Prognosis in Prostate AdenocarcinomaSemantic proximity Read

Molecular Characterization and Clinical Relevance of m6A Regulators in Metastatic Prostate CancerSemantic proximity Read

Targeting the MALAT1 gene with the CRISPR/Cas9 technique in prostate cancerSemantic proximity Read